Image For Activity Cover
Medications for Opioid Use Disorder
SUD 101 Core Curriculum Overview

Curriculum overview:  While healthcare professionals are often on the front lines of treating substance use disorders, most have limited (if any) training in this area. The SUD 101 Core Curriculum was created to provide a foundation of the current research, resources, and support needed to increase healthcare professionals’ competence and confidence in the care of their patients across the continuum of care. This activity, Medications for Opioid Use Disorder, is part of the 23-module curriculum. Please see below for a summary of module 5 out of 23:
Module 5 Overview
Title: Medications for Opioid Use Disorder 

Melissa B. Weimer, DO, MCR, Associate Professor of Medicine and Public Health, Medical Director, Yale Addiction Medicine Consult Service, Yale University School of Medicine & School of Public Health

Module Description: Opioid use disorder (OUD) has highly effective FDA approved medications for its treatment. This module reviews and compares pharmacological treatment options for individuals with OUD, including methadone, buprenorphine (SL and injectable formulations), and naltrexone (oral and long-acting intramuscular formulations). Current evidence for each medication is reviewed in detail and studies comparing each are discussed. The purpose and goal of medications for OUD is reviewed and different treatment models are presented. The module includes a discussion of a case vignette in which medication options for OUD are considered. 

Educational Objectives:

  • Identify the rationale for using medications to treat opioid use disorder
  • Describe effective medications for treating opioid use disorder
  • Explain the unique properties of methadone, buprenorphine, and extended release naltrexone
Availability: On-Demand
Expires on Jan 12, 2026
Cost: FREE
Credit Offered:
1.25 CME Credits
1.25 PA-CME Credits
1.25 Other Professionals Credits
1.25 Nursing Credits
1.25 Pharmacy Credits
1.25 IPCE Credits
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.

Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

8-Hour DEA Training Inquiries, email PCSS-MOUD.


Powered By